Fenugreek Trigonella foenum-graecum
Also called: fenugreek seed
Fenugreek, Trigonella foenum-graecum, is a plant whose seeds are used as a spice and in traditional medicine. The seeds smell and taste like maple syrup and are used as a flavoring.
- Category
- Botanical
- Part used
- Seed
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2023 meta-analysis (Int J Mol Sci) pooled 10 RCTs (706 adults with type 2 diabetes or prediabetes) of fenugreek seed, seed powder or seed extract versus placebo or no treatment; in some, both groups also took the same antidiabetic drugs (or valsartan, in one). [4]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CBlood sugar and weight1 topic
CHormones and reproduction1 topic
CPregnancy and infants1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood sugar in type 2 diabetes | C | Some research suggests fenugreek may lower blood sugar, but many studies were not high quality; NCCIH finds not enough high-quality evidence to judge. [1] |
| Breast milk supply | C | Cochrane 2020 (41 galactagogue trials): fenugreek was among natural products studied; milk-volume results could not be pooled, and evidence for fenugreek or fennel on infant weight was very low certainty. [2] |
| Menstrual cramps | C | Only a small number of studies exist, with low-quality evidence and uncertain effects. [1] |
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox likelihood score E: unlikely cause of clinically apparent liver injury (chapter last updated January 29, 2018).
Details and sources - Pregnancy and breastfeedingNCCIH: fenugreek is not safe for use during pregnancy in amounts greater than those found in food …
1 statement in the profile.
Details and sources - Interactions with medicines4 listed
Warfarin and antiplatelet drugs; Warfarin; SSRI antidepressants; Medicines in general
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications4 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
EU herbal monograph on Trigonella foenum-graecum L., semen (EMA/HMPC/179591/2018, Revision 1, 24 November 2021), traditional use for temporary loss …
Details and sources
- Not safe during pregnancy in amounts greater than those found in food; use in pregnancy has been linked to an increased risk of birth defects in animals and people. [1]
- Little is known about safety above food amounts while breastfeeding. [1]
- Can cause allergic reactions, including serious ones. Other side effects include diarrhea, nausea and other digestive symptoms; large doses may cause a harmful drop in blood sugar. [1]
Interactions
| With | What happens |
|---|---|
| Medicines in general, including those that lower blood sugar | NCCIH warns that large doses may lower blood sugar harmfully and advises talking with a provider before combining fenugreek with medicines. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Regulatory status
- US: sold as a dietary supplement ingredient; dietary supplements are not approved by the FDA before sale, and manufacturers are responsible for safety and labeling. [1]
- EU: the EMA HMPC lists fenugreek seed under traditional use, based on long-standing use rather than clinical trials, for temporary loss of appetite (oral) and minor skin inflammation (external) (EU herbal monograph revision 1 published 30/08/2022). [3]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Steroid saponins (LiverTox: the lipid- and glucose-lowering effects of fenugreek have been attributed to saponins) Saponins and steroidal glycosides [P6]
- Galactomannan fiber (mucilage) Polysaccharides [P7]
- Trigonelline Alkaloids (pyridine alkaloid) [P6]
- 4-Hydroxyisoleucine Amino acids, amines and peptides [P7]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 4 entries naming fenugreek (Trigonella foenum-graecum) (earliest NDI 8 submitted 1996-09-17; most recent NDI 1070 submitted 2018-03-19). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- LiverTox likelihood score E: unlikely cause of clinically apparent liver injury (chapter last updated January 29, 2018). [P6]
Interactions with medicines
- Warfarin and antiplatelet drugs: LiverTox: fenugreek has a potential to cause herb-drug interactions, particularly if taken in high doses with antiplatelet drugs and warfarin. [P6]
- Warfarin: MSK: case reports indicate fenugreek may potentiate the effects of warfarin (increased INR). [P7]
- SSRI antidepressants: A case report suggests supplemental fenugreek may increase the risk of serotonin syndrome; MSK advises people taking SSRIs to avoid fenugreek beyond typical food intake. [P7]
- Medicines in general: NCCIH: large doses of fenugreek may cause a harmful drop in blood sugar; people taking any medicine should talk with a health care provider before using it. [P5]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- EU herbal monograph on Trigonella foenum-graecum L., semen (EMA/HMPC/179591/2018, Revision 1, 24 November 2021), traditional use for temporary loss of appetite, adults and elderly: herbal tea 1–6 g seed daily in 250 mL boiling water before meals, or powdered seed 380–1100 mg three times daily (1140–3300 mg daily). Not recommended under 18 years. [P8]
Pregnancy and breastfeeding
- NCCIH: fenugreek is not safe for use during pregnancy in amounts greater than those found in food; its use has been linked to increased risks of birth defects in both animals and people. Little is known about safety above food amounts while breastfeeding. [P5]
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- NCCIH. Fenugreek (Last Updated: February 2025), 2025-02. nccih.nih.gov
- NIH LiverTox (NIDDK). Fenugreek (Last Update: January 29, 2018), 2018-01-29. ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Fenugreek (last updated December 7, 2023), 2023-12-07. mskcc.org
- European Medicines Agency, HMPC. European Union herbal monograph on Trigonella foenum-graecum L., semen, EMA/HMPC/179591/2018 (Final, Revision 1, 24 November 2021), 2021-11-24. ema.europa.eu
Sources
- NCCIH. Fenugreek (Last Updated: February 2025), 2025-02. nccih.nih.gov
- Foong SC, et al. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. Cochrane Database Syst Rev 2020 (CD011505), 2020-05-18. cochrane.org
- European Medicines Agency. Trigonellae foenugraeci semen (herbal medicine page), 2022-08-30. ema.europa.eu
- Kim J, et al. The effect of fenugreek in type 2 diabetes and prediabetes: a systematic review and meta-analysis of randomized controlled trials. Int J Mol Sci 2023;24(18):13999 (PMID 37762302), 2023-09-12. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.